Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy
PLOS Neglected Tropical Diseases · 26.06.2026 · 20 (6) · e0014385
DOI: 10.1371/journal.pntd.0014385 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 26.06.2026. Verfasst von Elaine J Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern California Keck School of Medicine, Los Angeles, California, United States of America. Hauptthemen laut MEDLINE: Leprosy, Lepromatous, Leprosy, Tuberculoid, Persons with Disabilities. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Leprosy remains an important cause of disability, even in non-endemic settings. Risk of neuropathy and functional impairment differs across the disease spectrum, yet contemporary U.S. data are limited.
Objective
To compare disability-related outcomes among patients with lepromatous versus tuberculoid leprosy in a large U.S. electronic health record (EHR) network.
Methods
Using the TriNetX U.S. Collaborative Research Network (2005–2025), patients with lepromatous (ICD-10-CM A30.4-A30.5) and tuberculoid (A30.1-A30.2) leprosy were identified. Disability-related outcomes were defined using ICD-10-CM and CPT codes. Patients with prior disability were excluded to assess incident events. Cohorts were propensity score-matched (1:1) on demographics and comorbidities. Odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) were calculated.
Results
A total of 341 lepromatous and 129 tuberculoid patients were identified (median follow-up 1,138 vs 1,021 days). Lepromatous leprosy was associated with higher risk of incident disability-related outcomes (OR 1.89, 95% CI 1.16-3.07). Kaplan-Meier analysis demonstrated lower outcome-free survival in the lepromatous cohort (HR 1.76, 95% CI 1.15-2.71).
Conclusions
In this U.S.-based cohort, lepromatous leprosy was associated with greater disability-related morbidity compared to tuberculoid leprosy. However, meaningful risk was observed across both subtypes, supporting structured longitudinal follow-up for all patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
- Department of Dermatology, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America.
- Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California, United States of America.
ORCID-Profile: Elaine J Ma
Zitieren
APA
Ma, E. J., Adler, B. L., Armstrong, A. W., & Ochoa, M. T. (2026). Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy. PLOS Neglected Tropical Diseases, 20(6), e0014385. https://doi.org/10.1371/journal.pntd.0014385
Vancouver
Ma EJ, Adler BL, Armstrong AW, Ochoa MT. Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy. PLOS Neglected Tropical Diseases. 2026;20(6):e0014385. doi:10.1371/journal.pntd.0014385
BibTeX
@article{Ma2026,
author = {Ma, Elaine J and Adler, Brandon L and Armstrong, April W and Ochoa, Maria T},
title = {Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {6},
pages = {e0014385},
doi = {10.1371/journal.pntd.0014385}
}
EUVIMED